OOIR: Observatory of International Research

Papers

(The TQCC of Seminars in Respiratory and Critical Care Medicine is 5. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-05-01 to 2024-05-01.)

Article	Citations
Prevention and Management of Delirium in the Intensive Care Unit	57
Cutaneous Sarcoidosis	42
Adenovirus: Epidemiology, Global Spread of Novel Types, and Approach to Treatment	37
Staphylococcus aureus Pneumonia in the Community	36
Ocular Sarcoidosis	32
Vasopressor Therapy in the Intensive Care Unit	30
Q Fever (Coxiella Burnetii)	24
FeNO in Asthma	24
Artificial Intelligence in the Intensive Care Unit	24
Determinants and Management of the Post–Pulmonary Embolism Syndrome	23
New Antibiotics for Hospital-Acquired Pneumonia and Ventilator-Associated Pneumonia	22
What Is the Utility of Measuring Lactate Levels in Patients with Sepsis and Septic Shock?	21
Cardiac Sarcoidosis	21
Management and Challenges of Severe Traumatic Brain Injury	20
Advanced Pulmonary Sarcoidosis	19
Physiological and Pathophysiological Consequences of Mechanical Ventilation	19
Mesenchymal Stem/Stromal Cells Therapy for Sepsis and Acute Respiratory Distress Syndrome	19
Nocardia spp.: A Rare Cause of Pneumonia Globally	19
Pathophysiology of Bronchiectasis	19
COVID-19 and Its Implications for Thrombosis and Anticoagulation	17
Monitoring Lung Injury Severity and Ventilation Intensity during Mechanical Ventilation	17
Obesity and Asthma	15
Primary Ciliary Dyskinesia	14
The Lung Allocation Score and Its Relevance	14
Microbial Epidemiology of the Cystic Fibrosis Airways: Past, Present, and Future	13

Lung Cancer Screening	13
Sarcoidosis-Associated Pulmonary Hypertension	12
Health-Related Quality of Life in Sarcoidosis	12
Elderly Patients in the Intensive Care Unit	12
Hepatic Sarcoidosis: Current Concepts and Treatments	11
Physical Therapy and Rehabilitation in Chronic Obstructive Pulmonary Disease Patients Admitted to the Intensive Care Unit	11
Severe Infections Due to Respiratory Viruses	10
Targeted Therapy for Non-Small Cell Lung Cancer	10
Small Cell Lung Cancer: Advances in Diagnosis and Management	9
Antimicrobial Stewardship in the ICU	9
The Role of Streptococcus pneumoniae in Community-Acquired Pneumonia	9
The Impact of Resistant Bacterial Pathogens including Pseudomonas aeruginosa and Burkholderia on Lung Transplant Outcomes	9
Endemic Fungi Presenting as Community-Acquired Pneumonia: A Review	9
Risk Stratification in Acute Pulmonary Embolism: The Latest Algorithms	9
Update on Sepsis Epidemiology in the Era of COVID-19	9
Pneumonic versus Nonpneumonic Exacerbations of Chronic Obstructive Pulmonary Disease	9
Fungal Infection in Lung Transplantation	9
Integrated Multiorgan Bedside Ultrasound for the Diagnosis and Management of Sepsis and Septic Shock	8
Methicillin-Resistant Staphylococcus aureus Hospital-Acquired Pneumonia/Ventilator-Associated Pneumonia	8
Melioidosis: A Neglected Cause of Community-Acquired Pneumonia	8
The Great Masquerader: Tuberculosis Presenting as Community-Acquired Pneumonia	8
The State of the Science in Patient-Reported Outcomes for Patients with Lung Cancer	8
Balancing Altered Calcium Metabolism with Bone Health in Sarcoidosis	8
Invasive Pulmonary Aspergillosis in Hospital and Ventilator-Associated Pneumonias	8
Middle East Respiratory Syndrome Coronavirus	8
Radiographic and Histopathologic Features in Sarcoidosis: A Pictorial Display	8
Life-Threatening Hemoptysis	8
Screening Sarcoidosis Patients for Occult Disease	8
The Burden of Neurosarcoidosis: Essential Approaches to Early Diagnosis and Treatment	7
Prevention of Venous Thromboembolism in Acutely Ill Medical Patients: A New Era	7
Mechanical Ventilation for COVID-19 Patients	7
Any Role of High-Dose Vitamin C for Septic Shock in 2021?	7
Antiviral Treatments for Influenza	7
Which Biomarkers Can Be Used as Diagnostic Tools for Infection in Suspected Sepsis?	7
Pseudomonas aeruginosa Pneumonia: Evolution of Antimicrobial Resistance and Implications for Therapy	7
Hospital-Acquired Pneumonia/Ventilator-Associated Pneumonia and Ventilator-Associated Tracheobronchitis in COVID-19	7
COVID-19 in Immunocompromised Patients: A Systematic Review	7
Pseudomonas aeruginosa in Bronchiectasis	7
Acute Rejection in the Modern Lung Transplant Era	7
Primary Graft Dysfunction	6
Mycobacteria: Selection of Transplant Candidates and Post–lung Transplant Outcomes	6
Viral Ventilator-Associated Pneumonia/Hospital-Acquired Pneumonia	6
Aspergillus-Associated Endophenotypes in Bronchiectasis	6
Invasive Pulmonary Aspergillosis in Chronic Obstructive Pulmonary Disease Exacerbations	6
Fulminant Clostridioides difficile Infection: A Review of Treatment Options for a Life-Threatening Infection	6
Community-Acquired Pneumonia: A Global Perspective	6
Emerging Resistance of Gram Negative Pathogens in Community-Acquired Pneumonia	6
Nebulized Antibiotics for Healthcare- and Ventilator-Associated Pneumonia	6
VATS and Minimally Invasive Resection in Early-Stage NSCLC	6
Respiratory Syncytial Virus	6

Chronic Obstructive Pulmonary Disease in the Intensive Care Unit: Antibiotic Treatment of Severe Chronic Obstructive Pulmonary Disease Exacerbations	5
Optimizing Fluid Resuscitation and Preventing Fluid Overload in Patients with Septic Shock	5
Bronchiectasis Exacerbations: Definitions, Causes, and Acute Management	5
Bronchoscopic Lung Volume Reduction for Emphysema: Review and Update	5
Clinical and Radiological Phenotypes and Endotypes	5
Pulmonary Embolism in Pregnancy	5
COVID-19 Vaccines—All You Want to Know	5
“Long Haulers”	5
Imaging of Lung Cancer Staging	5
Glucocorticoid Therapy in COVID-19	5
Nontuberculous Mycobacteria	5
Antibody-Mediated Rejection and Lung Transplantation	5
Lung Volume Reduction in Pulmonary Emphysema	5
End-of-Life Issues in Intensive Care Units	5
Chronic Lung Allograft Dysfunction: Evolving Concepts and Therapies	5
Extracorporeal Membrane Oxygenation as a Bridge to Lung Transplant	5